D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ADPT holding history
Adaptive Biotechnologies Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADPT overviewAll 13F holders of ADPTFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,625,859
- Value
- $99.2M
- % of portfolio
- 0.1%
- Quarters held
- 13
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,625,859 | $99.2M | 0.1% | +2,660,249+135.3% | Added | Holders |
| Q1 2026 | 1,965,610 | $27.3M | <0.1% | +62,925+3.3% | Added | Holders |
| Q4 2025 | 1,902,685 | $30.9M | <0.1% | +1,164,509+157.8% | Added | Holders |
| Q3 2025 | 738,176 | $11.0M | <0.1% | +129,896+21.4% | Added | Holders |
| Q2 2025 | 608,280 | $7.09M | <0.1% | +608,280 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −41,743−100.0% | Sold out | Holders |
| Q4 2023 | 41,743 | $204.5K | <0.1% | −89,526−68.2% | Reduced | Holders |
| Q3 2023 | 131,269 | $715.4K | <0.1% | +43,321+49.3% | Added | Holders |
| Q2 2023 | 87,948 | $590.1K | <0.1% | −139,781−61.4% | Reduced | Holders |
| Q1 2023 | 227,729 | $2.01M | <0.1% | +111,547+96.0% | Added | Holders |
| Q4 2022 | 116,182 | $887.6K | <0.1% | +57,498+98.0% | Added | Holders |
| Q3 2022 | 58,684 | $418.0K | <0.1% | −97,500−62.4% | Reduced | Holders |
| Q2 2022 | 156,184 | $1.26M | <0.1% | +23,981+18.1% | Added | Holders |
| Q1 2022 | 132,203 | $1.83M | <0.1% | +132,203 | New | Holders |